AMERICAN SOCIETY OF CLINICAL ONCOLOGY: Form 990, tax year 2017

View the entire original 990 at ProPublica ↗

Organization: AMERICAN SOCIETY OF CLINICAL ONCOLOGY (EIN 13-6180380)
Tax period: 2017-01-01 to 2017-12-31
Filed: 2018-11-09
IRS object ID: 201823139349300502
Schema version: 2017v2.3
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule I
Schedule J
Schedule K
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2018-11-09T05:42:29-06:00	ReturnTs
Tax Period End	2017-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	BDO USA LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	8401 GREENSBORO DRIVE 800	AddressLine1Txt
City	MCLEAN	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22102	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2017-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	136180380	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
In Care Of	% LINDA JENSEN CFO	InCareOfNm
Business Name Control	AMER	BusinessNameControlTxt
Phone	5714831300	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD Suite 800	AddressLine1Txt
City	ALEXANDRIA	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22314	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	LINDA JENSEN	PersonNm
Person Title	CFO	PersonTitleTxt
Phone	5714831300	PhoneNum
Signature	2018-11-07	SignatureDt
Discuss With Paid Preparer	Yes (true)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	Marc Berger	PreparerPersonNm
PTIN	P01871563	PTIN
Phone	7038930600	PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

Field	Value	IRS element (for citing)
I Pv4 Address	72.190.123.86	IPv4AddressTxt

Field	Value	IRS element (for citing)
Federal Original Submission Id	54621820183135000002	FederalOriginalSubmissionId
Federal Original Submission Id	2018-11-09	FederalOriginalSubmissionIdDt
Filing License Type	P	FilingLicenseTypeCd
At Submission Creation Device Id	453C092F4FAE56C85AAB65CCAB8DCA36E7EE5C2A	AtSubmissionCreationDeviceId
At Submission Filing Device Id	453C092F4FAE56C85AAB65CCAB8DCA36E7EE5C2A	AtSubmissionFilingDeviceId

Field	Value	IRS element (for citing)
Tax	2017	TaxYr
Build TS	2019-02-21 02:37:17Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	CLIFFORD HUDIS MD CEO	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD 800	AddressLine1Txt
City	ALEXANDRIA	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22314	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$182,338,529	GrossReceiptsAmt
Group Return For Affiliates	false	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.ASCO.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1964	FormationYr
Legal Domicile State	NY	LegalDomicileStateCd
Activity Or Mission	ASCO IS A PROFESSIONAL ONCOLOGY SOCIETY COMMITTED TO CONQUERING CANCER THROUGH RESEARCH, EDUCATION, PREVENTION AND DELIVERY OF HIGH QUALITY PATIENT CARE.	ActivityOrMissionDesc
Voting Members Governing Body	18	VotingMembersGoverningBodyCnt
Voting Members Independent	18	VotingMembersIndependentCnt
Total Employee	554	TotalEmployeeCnt
Total Volunteers	1200	TotalVolunteersCnt
Total Gross UBI	$18,154,776	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$4,472,874	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$11,941,446	PYContributionsGrantsAmt
CY Contributions Grants	$9,978,694	CYContributionsGrantsAmt
PY Program Service Revenue	$96,414,990	PYProgramServiceRevenueAmt
CY Program Service Revenue	$111,649,833	CYProgramServiceRevenueAmt
PY Investment Income	$3,691,563	PYInvestmentIncomeAmt
CY Investment Income	$20,138,405	CYInvestmentIncomeAmt
PY Other Revenue	$2,762,079	PYOtherRevenueAmt
CY Other Revenue	$2,771,589	CYOtherRevenueAmt
PY Total Revenue	$114,810,078	PYTotalRevenueAmt
CY Total Revenue	$144,538,521	CYTotalRevenueAmt
PY Grants And Similar Paid	$4,184,032	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$3,197,652	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$48,653,534	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$54,588,773	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$0	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$0	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$6,454,232	CYTotalFundraisingExpenseAmt
PY Other Expenses	$64,090,122	PYOtherExpensesAmt
CY Other Expenses	$78,774,427	CYOtherExpensesAmt
PY Total Expenses	$116,927,688	PYTotalExpensesAmt
CY Total Expenses	$136,560,852	CYTotalExpensesAmt
PY Revenues Less Expenses	-$2,117,610	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$7,977,669	CYRevenuesLessExpensesAmt
Total Assets BOY	$213,011,354	TotalAssetsBOYAmt
Total Assets EOY	$228,266,590	TotalAssetsEOYAmt
Total Liabilities BOY	$111,127,454	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$117,378,146	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$101,883,900	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$110,888,444	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	SEE SCHEDULE O	MissionDesc
Significant New Program Srvc	false	SignificantNewProgramSrvcInd
Significant Change	false	SignificantChangeInd
Expense	$37,497,374	ExpenseAmt
Grant	$3,197,652	GrantAmt
Revenue	$69,305,344	RevenueAmt
Desc	SEE SCHEDULE O	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$31,882,859	ExpenseAmt
Revenue	$13,991,477	RevenueAmt
Desc	SEE SCHEDULE O	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$13,653,472	ExpenseAmt
Revenue	$19,886,393	RevenueAmt
Desc	SEE SCHEDULE O	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$32,958,701	TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant	$3,197,652	TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue	$8,466,619	TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses	$115,992,406	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (true)	DescribedInSection501c3Ind
Schedule B Required	Yes (true)	ScheduleBRequiredInd
Political Campaign Acty	false	PoliticalCampaignActyInd
Lobbying Activities	Yes (true)	LobbyingActivitiesInd
Subject To Proxy Tax	false	SubjectToProxyTaxInd
Donor Advised Fund	false	DonorAdvisedFundInd
Conservation Easements	false	ConservationEasementsInd
Collections Of Art	false	CollectionsOfArtInd
Credit Counseling	false	CreditCounselingInd
Temp Or Permanent Endowments	false	TempOrPermanentEndowmentsInd
Report Land Building Equipment	Yes (true)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	Yes (true)	ReportInvestmentsOtherSecInd
Report Program Related Invst	false	ReportProgramRelatedInvstInd
Report Other Assets	false	ReportOtherAssetsInd
Report Other Liabilities	Yes (true)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (true)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	false	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (true)	ConsolidatedAuditFinclStmtInd
School Operating	false	SchoolOperatingInd
Foreign Office	Yes (true)	ForeignOfficeInd
Foreign Activities	Yes (true)	ForeignActivitiesInd
More Than5000 K To Org	Yes (true)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	Yes (true)	MoreThan5000KToIndividualsInd
Professional Fundraising	false	ProfessionalFundraisingInd
Fundraising Activities	false	FundraisingActivitiesInd
Gaming Activities	false	GamingActivitiesInd
Operate Hospital	false	OperateHospitalInd
Grants To Organizations	Yes (true)	GrantsToOrganizationsInd
Grants To Individuals	false	GrantsToIndividualsInd
Schedule J Required	Yes (true)	ScheduleJRequiredInd
Tax Exempt Bonds	Yes (true)	TaxExemptBondsInd
Invest Tax Exempt Bonds	false	InvestTaxExemptBondsInd
Escrow Account	false	EscrowAccountInd
On Behalf Of Issuer	false	OnBehalfOfIssuerInd
Engaged In Excess Benefit Trans	false	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	false	PYExcessBenefitTransInd
Loan Outstanding	false	LoanOutstandingInd
Grant To Related Person	false	GrantToRelatedPersonInd
Business Rln With Org Mem	false	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	false	BusinessRlnWithFamMemInd
Business Rln With Officer Ent	false	BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri	false	DeductibleNonCashContriInd
Deductible Art Contribution	false	DeductibleArtContributionInd
Terminate Operations	false	TerminateOperationsInd
Partial Liquidation	false	PartialLiquidationInd
Disregarded Entity	Yes (true)	DisregardedEntityInd
Related Entity	Yes (true)	RelatedEntityInd
Related Organization Ctrl Ent	Yes (true)	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	Yes (true)	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	false	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	false	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (true)	ScheduleORequiredInd
IRP Document	454	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (true)	BackupWthldComplianceInd
Employee	554	EmployeeCnt
Employment Tax Returns Filed	Yes (true)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	Yes (true)	UnrelatedBusIncmOverLimitInd
Form990 T Filed	Yes (true)	Form990TFiledInd
Foreign Financial Account	false	ForeignFinancialAccountInd
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTransInd
Taxable Party Notification	false	TaxablePartyNotificationInd
Nondeductible Contributions	false	NondeductibleContributionsInd
Quid Pro Quo Contributions	false	QuidProQuoContributionsInd
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	false	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	false	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	false	IndoorTanningServicesInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	18	GoverningBodyVotingMembersCnt
Independent Voting Member	18	IndependentVotingMemberCnt
Family Or Business Rln	false	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	false	DelegationOfMgmtDutiesInd
Change To Org Documents	false	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	false	MaterialDiversionOrMisuseInd
Members Or Stockholders	Yes (true)	MembersOrStockholdersInd
Election Of Board Members	Yes (true)	ElectionOfBoardMembersInd
Decisions Subject To Approva	Yes (true)	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (true)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (true)	MinutesOfCommitteesInd
Officer Mailing Address	false	OfficerMailingAddressInd
Local Chapters	false	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (true)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (true)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (true)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (true)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (true)	WhistleblowerPolicyInd
Document Retention Policy	Yes (true)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (true)	CompensationProcessCEOInd
Compensation Process Other	Yes (true)	CompensationProcessOtherInd
Investment In Joint Venture	false	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	LINDA JENSEN CFO	PersonNm
Phone	5714831300	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD SUITE 800	AddressLine1Txt
City	ALEXANDRIA	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22314	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (40 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Key EmployeeKeyEmployeeInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd
Bruce E Johnson MD FASCO
President	1.0	0.0	Yes (X)	Yes (X)	$0	$0	$0
Monica Bertagnolli MD FASCO
President-Elect	1.0	0.0	Yes (X)	Yes (X)	$0	$0	$0
Daniel F Hayes MD FASCO
Immediate Past President	1.0	0.0	Yes (X)	Yes (X)	$0	$0	$0
Craig Nichols MD FACP
Treasurer	1.0	0.0	Yes (X)	Yes (X)	$0	$0	$0
Peter C Adamson MD
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Charles DBlankeMDFACPFASCO
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Linda D Bosserman MD FACP
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Walter J Curran JrMDFACR
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Stephen B Edge MD FASCO
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Paulo Hoff MD FACP
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Arti Hurria MD
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Maha HAHussainMDFACPFASCO
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
David Khayat MD PhD FASCO
Board Member	1.0	0.0	Yes (X)		$15,000	$0	$0
Neal J Meropol MD FASCO
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Therese M Mulvey MD FASCO
Board Member	1.0	0.0	Yes (X)		$1,500	$0	$0
J Chris Nunnink MD FASCO
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Jacob Verweij MD PhD
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Reshma Jagsi MD Dphil
Board Member	1.0	0.0	Yes (X)		$6,000	$0	$0
Michael P KostyMDFACPFASCO
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Eric J Small MD FASCO
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Jedd Wolchok MD FASCO
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
JULIE M VOSE MD MBA FASCO
BOARD MEMBER	1.0	0.0	Yes (X)		$0	$0	$0
Clifford AHudisMDFACPFASCO
CEO, Ex-officio Director	30.0	7.5	Yes (X)	Yes (X)	$807,692	$0	$24,119
Dina Michels Esq
Senior VP, CLO, SECRETARY	30.0	7.5		Yes (X)	$549,327	$0	$38,519
Linda Jensen CPA
VP, Chief Financial Officer	30.0	7.5		Yes (X)	$394,615	$0	$34,207
Richard Schilsky MD
SVP, Chief Medical Officer	30.0	7.5			$539,346	$0	$34,207	Yes (X)
Nancy Daly MS MPH
Executive VP, CPO, CC	1.0	36.5			$362,097	$0	$33,799	Yes (X)
Kevin Fitzpatrick
CEO, CancerLinQ	37.5	0.0			$464,423	$0	$38,519	Yes (X)
Jamie Von Roenn MD
VP, Education	37.5	0.0			$398,417	$0	$34,207	Yes (X)
Bernie Khoo
VP, Integrated Media	35.0	2.5			$409,538	$0	$39,902	Yes (X)
Deborah Kamin RN PHD
VP, POLICY AND ADVOCACY	37.5	0.0			$284,525	$0	$34,207	Yes (X)
David Sampson
VP, Publications	37.5	0.0			$234,615	$0	$35,115	Yes (X)
Krista Barnes
VP, Member Services	37.5	0.0			$219,615	$0	$33,990	Yes (X)
Mandy Davis-Aitken
VP, Meeting Services	37.5	0.0			$162,611	$0	$19,292	Yes (X)
JEAN COLVARD
VP MEETING SERVICES	30.0	7.5			$149,577	$0	$14,732	Yes (X)
Stephen Grubbs MD
VP, Clinical Affairs	37.5	0.0			$379,623	$0	$31,375		Yes (X)
Robert Miller MD
VP, Quality	37.5	0.0			$361,210	$0	$38,519		Yes (X)
Kristin Ludwig
VP, Communications	37.5	0.0			$269,567	$0	$20,996		Yes (X)
DAVID DORNSTREICH
DIVISION DIR., MARKET STRAT.	37.5	0.0			$255,750	$0	$32,726		Yes (X)
JENNIFER WONG
CHIEF, STRATEGIC ALLIANCES	37.5	0.0			$254,517	$0	$30,030		Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$6,519,565	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$568,461	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	132	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	false	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (true)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	false	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
Vector Oncology
6555 Quince Rd Suite 400	MEMPHIS	TN	38119	Technology Services	$3,167,074
SAP PUBLIC SERVICES INC
PO BOX 7780-824024	PHILADELPHIA	PA	19182	TECHNOLOGY SERVICES	$3,897,600
THE CORKERY GROUP
260 FIFTH AVE	NEW YORK	NY	10001	PUBLIC RELATIONS	$1,471,412
Polsinelli Shughart PC
1152 15th St NW	WASHINGTON	DC	20005	POLICY CONSULTING	$570,090
J Spargo Associates Inc
11208 Waples Mill Rd	FAIRFAX	VA	22030	MEETING Services	$1,809,346

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	19	CntrctRcvdGreaterThan100KCnt
Related Organizations	$9,856,323	RelatedOrganizationsAmt
Government Grants	$122,371	GovernmentGrantsAmt
Total Contributions	$9,978,694	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (5 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt	Unrelated Business RevenueUnrelatedBusinessRevenueAmt
EDUCATION MEETINGS & PRODUCTS	900099	$48,297,206	$48,297,206
ADVERTISING	541800	$16,692,134		$16,692,134
PUBLICATIONS	511190	$14,775,909	$14,775,909
MEMBERSHIP	900099	$12,927,503	$12,927,503
EXHIBITS	900099	$16,357,423	$16,357,423

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$2,599,658	TotalRevenueColumnAmt
Related Or Exempt Func Income	$939,103	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$1,660,555	UnrelatedBusinessRevenueAmt

Field	Value	IRS element (for citing)
Total Program Service Revenue	$111,649,833	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$3,248,604	TotalRevenueColumnAmt
Exclusion	$3,248,604	ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$2,720,643	TotalRevenueColumnAmt
Exclusion	$2,720,643	ExclusionAmt

Gross Rents GrossRentsGrp

Field	Value	IRS element (for citing)
Real	$1,092,313	RealAmt

Less Rental Expenses LessRentalExpensesGrp

Field	Value	IRS element (for citing)
Real	$1,361,776	RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	-$269,463	RealAmt
Personal	$0	PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$269,463	TotalRevenueColumnAmt
Unrelated Business Revenue	-$269,463	UnrelatedBusinessRevenueAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$53,328,033	SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$36,438,232	SecuritiesAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$16,889,801	SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$16,889,801	TotalRevenueColumnAmt
Exclusion	$16,889,801	ExclusionAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$0	FundraisingGrossIncomeAmt
Fundraising Direct Expenses	$0	FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Field	Value	IRS element (for citing)
Gaming Gross Income	$0	GamingGrossIncomeAmt
Gaming Direct Expenses	$0	GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Field	Value	IRS element (for citing)
Gross Sales Of Inventory	$0	GrossSalesOfInventoryAmt
Cost Of Goods Sold	$0	CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	ExclusionExclusionAmt	Unrelated Business RevenueUnrelatedBusinessRevenueAmt
MAILING LIST	511120	$248,859	$248,859
TENANT PARKING	900099	$71,550		$71,550

Field	Value	IRS element (for citing)
Other Revenue Total	$320,409	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$144,538,521	TotalRevenueColumnAmt
Related Or Exempt Func Income	$93,297,144	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$18,154,776	UnrelatedBusinessRevenueAmt
Exclusion	$23,107,907	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$2,488,950	TotalAmt
Program Services	$2,488,950	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$708,702	TotalAmt
Program Services	$708,702	ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$7,418,978	TotalAmt
Program Services	$5,638,423	ProgramServicesAmt
Management And General	$1,187,037	ManagementAndGeneralAmt
Fundraising	$593,518	FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$35,935,944	TotalAmt
Program Services	$30,545,552	ProgramServicesAmt
Management And General	$4,671,673	ManagementAndGeneralAmt
Fundraising	$718,719	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$3,175,200	TotalAmt
Program Services	$2,762,424	ProgramServicesAmt
Management And General	$412,776	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$4,775,466	TotalAmt
Program Services	$4,154,655	ProgramServicesAmt
Management And General	$620,811	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$3,283,185	TotalAmt
Program Services	$2,856,371	ProgramServicesAmt
Management And General	$426,814	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$1,016,315	TotalAmt
Program Services	$739,290	ProgramServicesAmt
Management And General	$277,025	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$397,875	TotalAmt
Program Services	$99,469	ProgramServicesAmt
Management And General	$298,406	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$124,202	TotalAmt
Program Services	$124,202	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$780,641	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$780,641	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$18,183,107	TotalAmt
Program Services	$16,638,180	ProgramServicesAmt
Management And General	$1,544,927	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$571,444	TotalAmt
Program Services	$516,944	ProgramServicesAmt
Management And General	$54,500	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$2,623,814	TotalAmt
Program Services	$2,282,718	ProgramServicesAmt
Management And General	$341,096	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$14,670,947	TotalAmt
Program Services	$13,350,562	ProgramServicesAmt
Management And General	$1,026,966	ManagementAndGeneralAmt
Fundraising	$293,419	FundraisingAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$5,282,008	TotalAmt
Program Services	$4,806,627	ProgramServicesAmt
Management And General	$369,741	ManagementAndGeneralAmt
Fundraising	$105,640	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$4,716,989	TotalAmt
Program Services	$4,150,950	ProgramServicesAmt
Management And General	$566,039	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$11,967,451	TotalAmt
Program Services	$10,866,446	ProgramServicesAmt
Management And General	$957,396	ManagementAndGeneralAmt
Fundraising	$143,609	FundraisingAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$3,245,301	TotalAmt
Program Services	$2,823,412	ProgramServicesAmt
Management And General	$324,530	ManagementAndGeneralAmt
Fundraising	$97,359	FundraisingAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$654,390	TotalAmt
Program Services	$588,951	ProgramServicesAmt
Management And General	$65,439	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
PRINTING & PRODUCTION	$4,661,430	$4,607,040	$52,422	$1,968
DEVELOPMENT FEE TO CC	$4,500,000			$4,500,000
UBI TAX	$2,058,568	$2,058,568
POSTAGE & SHIPPING	$1,642,738	$1,610,038	$32,700

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$1,677,207	TotalAmt
Program Services	$1,573,932	ProgramServicesAmt
Management And General	$103,275	ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$136,560,852	TotalAmt
Program Services	$115,992,406	ProgramServicesAmt
Management And General	$14,114,214	ManagementAndGeneralAmt
Fundraising	$6,454,232	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$5,310,802	BOYAmt
EOY	$8,382,288	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$6,539,938	BOYAmt
EOY	$7,615,148	EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$5,101,280	BOYAmt
EOY	$4,792,902	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$73,499,532	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$23,329,898	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$50,116,812	BOYAmt
EOY	$50,169,634	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$118,931,834	BOYAmt
EOY	$132,611,260	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$24,313,722	BOYAmt
EOY	$24,593,902	EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$2,696,966	BOYAmt
EOY	$101,456	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$213,011,354	BOYAmt
EOY	$228,266,590	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$7,030,425	BOYAmt
EOY	$9,930,921	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$26,537,743	BOYAmt
EOY	$33,691,508	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$38,400,000	BOYAmt
EOY	$38,400,000	EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$39,159,286	BOYAmt
EOY	$35,355,717	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$111,127,454	BOYAmt
EOY	$117,378,146	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows SFAS117	Yes (X)	OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$101,883,900	BOYAmt
EOY	$110,888,444	EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$101,883,900	BOYAmt
EOY	$110,888,444	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$213,011,354	BOYAmt
EOY	$228,266,590	EOYAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	Yes (X)	InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss	$7,977,669	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	-$263,108	NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets	$1,289,983	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	false	AccountantCompileOrReviewInd
FS Audited	Yes (true)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consolidated Basis Fincl Stmt	Yes (X)	ConsolidatedBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (true)	AuditCommitteeInd
Federal Grant Audit Required	false	FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Publicly Supported Org509a2	Yes (X)	PubliclySupportedOrg509a2Ind

Gifts Grants Contris Rcvd509 GiftsGrantsContrisRcvd509Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$8,477,875	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$9,775,055	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$13,960,857	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$11,941,446	CurrentTaxYearMinus1YearAmt
Current Tax Year	$9,978,694	CurrentTaxYearAmt
Total	$54,133,927	TotalAmt

Gross Receipts Admissions GrossReceiptsAdmissionsGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$76,312,383	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$83,008,682	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$88,958,786	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$78,719,498	CurrentTaxYearMinus1YearAmt
Current Tax Year	$93,297,144	CurrentTaxYearAmt
Total	$420,296,493	TotalAmt

Gross Receipts Non Unrlt Bus GrossReceiptsNonUnrltBusGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Tax Rev Levied Orgnztnl Bnft509 TaxRevLeviedOrgnztnlBnft509Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Govt Furn Srvc Fclts Vl509 GovtFurnSrvcFcltsVl509Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Total509 Total509Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$84,790,258	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$92,783,737	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$102,919,643	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$90,660,944	CurrentTaxYearMinus1YearAmt
Current Tax Year	$103,275,838	CurrentTaxYearAmt
Total	$474,430,420	TotalAmt

Amounts Rcvd Dsqlfy Person AmountsRcvdDsqlfyPersonGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$11,456,835	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$12,876,427	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$13,914,277	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$11,641,675	CurrentTaxYearMinus1YearAmt
Current Tax Year	$9,856,323	CurrentTaxYearAmt
Total	$59,745,537	TotalAmt

Substantial Contributors Amt SubstantialContributorsAmtGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Subst And Dsqlfy Prsns Tot SubstAndDsqlfyPrsnsTotGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$11,456,835	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$12,876,427	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$13,914,277	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$11,641,675	CurrentTaxYearMinus1YearAmt
Current Tax Year	$9,856,323	CurrentTaxYearAmt
Total	$59,745,537	TotalAmt

Field	Value	IRS element (for citing)
Public Support Total509	$414,684,883	PublicSupportTotal509Amt

Gross Investment Income509 GrossInvestmentIncome509Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$5,333,603	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$5,821,197	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$6,401,944	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$5,651,063	CurrentTaxYearMinus1YearAmt
Current Tax Year	$5,969,247	CurrentTaxYearAmt
Total	$29,177,054	TotalAmt

Post1975 UBTI Post1975UBTIGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Investment Income And UBTI InvestmentIncomeAndUBTIGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$5,333,603	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$5,821,197	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$6,401,944	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$5,651,063	CurrentTaxYearMinus1YearAmt
Current Tax Year	$5,969,247	CurrentTaxYearAmt
Total	$29,177,054	TotalAmt

Net Income From Other UBI NetIncomeFromOtherUBIGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$3,403,799	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$3,584,676	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$3,133,751	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$3,414,649	CurrentTaxYearMinus1YearAmt
Current Tax Year	$2,871,782	CurrentTaxYearAmt
Total	$16,408,657	TotalAmt

Other Income509 OtherIncome509Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus2 Years	$306,781	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$277,776	CurrentTaxYearMinus1YearAmt
Current Tax Year	$248,859	CurrentTaxYearAmt
Total	$833,416	TotalAmt

Total Support Calendar Year TotalSupportCalendarYearGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$93,527,660	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$102,189,610	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$112,762,119	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$100,004,432	CurrentTaxYearMinus1YearAmt
Current Tax Year	$112,365,726	CurrentTaxYearAmt
Total	$520,849,547	TotalAmt

Field	Value	IRS element (for citing)
Public Support CY509	0.79617	PublicSupportCY509Pct
Public Support PY509	0.78416	PublicSupportPY509Pct
Investment Income CY	0.05602	InvestmentIncomeCYPct
Investment Income PY	0.08844	InvestmentIncomePYPct
Thirty Thr Pct Suprt Tests CY509	Yes (X)	ThirtyThrPctSuprtTestsCY509Ind

Schedule B IRS990ScheduleB

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$2,905	FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$291,378	FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$294,283	FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$115,698,123	FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$115,992,406	FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$1,000,000	FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$250,000	FilingOrganizationsTotalAmt

Field	Value	IRS element (for citing)
Tot Lbbyng Grassroot Mns Non Tx		TotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non Tx		TotLbbyExpendMnsLbbyngNonTxGrp

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$1,000,000	CurrentYearMinus3Amt
Current Year Minus2	$1,000,000	CurrentYearMinus2Amt
Current Year Minus1	$1,000,000	CurrentYearMinus1Amt
Current Year	$1,000,000	CurrentYearAmt
Total	$4,000,000	TotalAmt

Field	Value	IRS element (for citing)
Lobbying Ceiling	$6,000,000	LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$171,707	CurrentYearMinus3Amt
Current Year Minus2	$212,384	CurrentYearMinus2Amt
Current Year Minus1	$259,559	CurrentYearMinus1Amt
Current Year	$291,378	CurrentYearAmt
Total	$935,028	TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$250,000	CurrentYearMinus3Amt
Current Year Minus2	$250,000	CurrentYearMinus2Amt
Current Year Minus1	$250,000	CurrentYearMinus1Amt
Current Year	$250,000	CurrentYearAmt
Total	$1,000,000	TotalAmt

Field	Value	IRS element (for citing)
Grassroots Ceiling	$1,500,000	GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$10,098	CurrentYearMinus3Amt
Current Year Minus2	$8,424	CurrentYearMinus2Amt
Current Year Minus1	$3,346	CurrentYearMinus1Amt
Current Year	$2,905	CurrentYearAmt
Total	$24,773	TotalAmt

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Art Public Exhibition Amounts		ArtPublicExhibitionAmountsGrp
Held Works Art		HeldWorksArtGrp
CY Minus3 Yr Endwmt Fund		CYMinus3YrEndwmtFundGrp
CY Minus4 Yr Endwmt Fund		CYMinus4YrEndwmtFundGrp

Land LandGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$7,342,677	OtherCostOrOtherBasisAmt
Book Value	$7,342,677	BookValueAmt

Buildings BuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$46,941,779	OtherCostOrOtherBasisAmt
Depreciation	$11,418,115	DepreciationAmt
Book Value	$35,523,664	BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$773,776	OtherCostOrOtherBasisAmt
Depreciation	$121,259	DepreciationAmt
Book Value	$652,517	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$5,404,497	OtherCostOrOtherBasisAmt
Depreciation	$3,278,932	DepreciationAmt
Book Value	$2,125,565	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$13,036,803	OtherCostOrOtherBasisAmt
Depreciation	$8,511,592	DepreciationAmt
Book Value	$4,525,211	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$50,169,634	TotalBookValueLandBuildingsAmt
Financial Derivatives		FinancialDerivativesGrp
Closely Held Equity Interests		CloselyHeldEquityInterestsGrp

Other Securities OtherSecuritiesGrp (2 entries)

DescDesc	Book ValueBookValueAmt	Method ValuationMethodValuationCd
ALPHAKEYS DOUBLE BLACK DIAMOND	$10,351,946	F
UBS MILLENNIUM FUND (OFFSHORE)	$14,241,956	F

Field	Value	IRS element (for citing)
Total Book Value Securities	$24,593,902	TotalBookValueSecuritiesAmt
Federal Income Tax Liability	$0	FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (3 entries)

DescDesc	AmtAmt
LIABILITY UNDER INTEREST RATE SWAP	$12,949,327
TAXABLE BOND PAYABLE	$19,461,946
DUE TO AFFILIATE	$2,944,444

Field	Value	IRS element (for citing)
Total Liability	$35,355,717	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$146,146,531	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	-$263,108	NetUnrealizedGainsInvstAmt
Other Revenue	$1,289,983	OtherRevenueAmt
Revenue Not Reported	$1,026,875	RevenueNotReportedAmt
Revenue Subtotal	$145,119,656	RevenueSubtotalAmt
Investment Expenses Not Incld	$780,641	InvestmentExpensesNotIncldAmt
Other Revenues Not Included	-$1,361,776	OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt	-$581,135	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$144,538,521	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$137,141,987	TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included	$1,361,776	OtherExpensesIncludedAmt
Expenses Not Reported	$1,361,776	ExpensesNotReportedAmt
Expenses Subtotal	$135,780,211	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$780,641	InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt	$780,641	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$136,560,852	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART X, LINE 2	In accordance with gaap, the organization may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The organization believes that it has appropriate support for tax positions taken, and therefore, does not have uncertain tax positions that are material to the consolidated financial statements. Generally, the organization is no longer subject to income tax examinations by the U.S. federal, state or local tax authorities for years prior to December 31, 2014.
PART XI, LINE 2D	GAIN ON INTEREST RATE SWAP $1,289,983
PART XI, LINE 4B	RENTAL EXPENSES -$1,361,776
PART XII, LINE 2D	RENTAL EXPENSES $1,361,776

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (9 entries)

RegionRegionTxt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
East Asia and the Pacific	Program Services	OUTREACH & EDUCATIONAL	$154,009
Europe (Including Iceland and Greenland)	Program Services	OUTREACH & EDUCATIONAL	$29,658
North America	Program Services	OUTREACH & EDUCATIONAL	$79,944
Russia and the Newly Independent States	Program Services	OUTREACH & EDUCATIONAL	$26,856
South America	Program Services	OUTREACH & EDUCATIONAL	$108,780
South Asia	Program Services	OUTREACH & EDUCATIONAL	$162,282
Sub-Saharan Africa	Program Services	OUTREACH & EDUCATIONAL	$126,281
Central America and the Caribbean	Program Services	OUTREACH & EDUCATIONAL	$20,892
Central America and the Caribbean	Investments		$10,351,943

Field	Value	IRS element (for citing)
Subtotal Spent	$11,060,645	SubtotalSpentAmt
Total Spent	$11,060,645	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (5 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt
Europe (Including Iceland and Greenland)	contribution	$93,767	check
Europe (Including Iceland and Greenland)	contribution	$7,375	check
North America	contribution	$20,000	check
Sub-Saharan Africa	contribution	$6,370	check
Sub-Saharan Africa	contribution	$5,200	check

Field	Value	IRS element (for citing)
Total501c3 Org	5	Total501c3OrgCnt

Foreign Individuals Grants ForeignIndividualsGrantsGrp (8 entries)

Type Of AssistanceTypeOfAssistanceTxt	RegionRegionTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt	Non Cash AssistanceNonCashAssistanceAmt	Description Of Non Cash AsstDescriptionOfNonCashAsstTxt	Valuation Method UsedValuationMethodUsedDesc
idea award	East Asia and the Pacific	5	$6,140	Cash/Check	$8,866	Travel	Book
idea award	Europe (Including Iceland and Greenland)	1	$1,260	Cash/Check	$1,630	travel	book
idea award	North America	4	$4,720	Cash/Check	$3,069	travel	book
idea award	South America	3	$3,300	Cash/Check	$7,299	travel	book
idea award	South Asia	5	$6,105	Cash/Check	$9,707	travel	book
idea award	Sub-Saharan Africa	4	$4,880	Cash/Check	$7,424	travel	book
idea award	Central America and the Caribbean	1	$1,100	Cash/Check	$936	travel	book
idea award	Russia and the Newly Independent States	1	$1,260	Cash/Check	$1,357	travel	book

Field	Value	IRS element (for citing)
Transfer To Foreign Corp	Yes (true)	TransferToForeignCorpInd
Interest In Foreign Trust	false	InterestInForeignTrustInd
Foreign Corp Ownership	false	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	false	PassiveForeignInvestmestCoInd
Foreign Partnership	false	ForeignPartnershipInd
Boycott Countries	false	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE F, PART I, LINE 1	FormAndLineReferenceDesc
Explanation	INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD (IDEA) - THE INTERNATIONAL DEVELOPMENT AND EDUCATION AWARDS PROVIDE SUPPORT FOR EARLY-CAREER ONCOLOGISTS IN DEVELOPING COUNTRIES TO LEARN ABOUT ONCOLOGY CARE AND RESEARCH BY ESTABLISHING STRONG RELATIONSHIPS WITH LEADING ASCO ONCOLOGISTS WHO SERVE AS SCIENTIFIC MENTORS TO EACH RECIPIENT. RECIPIENTS LEARN ABOUT QUALITY CANCER CARE AND RESEARCH BY ATTENDING THE ASCO ANNUAL MEETING AND VISITING THEIR MENTOR'S CANCER CENTER IN THE UNITED STATES AND CANADA. RECIPIENTS ARE EXPECTED TO SHARE THE KNOWLEDGE AND TRAINING THEY RECEIVE THROUGH THE PROGRAM WITH COLLEAGUES IN THEIR HOME COUNTRIES ONCE THEY RETURN. IDEAS ARE PROVIDED TO RECIPIENTS BASED ON MERIT THROUGH A PEER REVIEW PROCESS USING ESTABLISHED ELIGIBILITY CRITERIA. IDEA RECIPIENTS ARE REQUIRED TO AGREE TO TERMS AND CONDITIONS APPLICABLE TO THE IDEA, ARE REQUIRED TO COMMUNICATE WITH THEIR MENTORS, TO ATTEND ALL IDEA-RELATED EVENTS, TO SUBMIT EVALUATIONS AFTER THE ANNUAL MEETING AND MENTOR SITE VISIT, AND TO SUBMIT ONE-YEAR REPORTS.	ExplanationTxt

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (14 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt
Conquer Cancer Foundation
2318 Mill Rd Ste 800	Alexandria	VA	22314	311667995	501(c)(3)	$1,617,000	Contribution
Regents of the University of Michigan
300 N Ingalls St	Ann Arbor	MI	48109	386006309	501(c)(3)	$126,240	Contribution
University of Nebraska Medical Center
985520 Nebraska Medical Ctr	Omaha	NE	68198	911858433	501(c)(3)	$11,405	Contribution
Testicular Cancer Commons
275 Seventh Ave 22nd Fl	Portland	OR	97209	271348551	501(c)(3)	$82,810	Contribution
Dana Farber Cancer Institute
450 Brookline Ave	Boston	MA	02215	042263040	501(c)(3)	$165,400	Contribution
Friends of Cancer Research
3299 K Street NW	Washington	DC	20007	521983273	501(c)(3)	$35,000	Contribution
National Academy of Sciences
2101 Constitution Ave	Washington	DC	20418	530196932	501(c)(3)	$16,500	Contribution
Duke University Medical Center
2424 Erwin Rd Suite 601	Durham	NC	27705	560532129	501(c)(3)	$25,000	Contribution
National Coalition for Cancer Survivorship
1010 Wayne Ave 770	Silver Spring	MD	20910	850357897	501(c)(3)	$10,000	Contribution
Health Volunteers Overseas
1900 L St NW 310	washington	DC	20036	521485477	501(C)(3)	$10,000	contribution
WETA
3939 Campbell Avenue	Arlington	VA	22206	530242992	501(c)(3)	$175,000	Contribution
CancerCare
275 Seventh Ave 22nd Fl	New York	NY	10001	131825919	501(c)(3)	$105,000	Contribution
Brigham & Women's Hospital
75 Francis St T 1 Rm 220	Boston	MA	02215	042312909	501(c)(3)	$46,667	Contribution
Susan G Komen Foundation
5005 LBJ Freeway Ste 250	Dallas	TX	75244	751835298	501(c)(3)	$25,000	Contribution

Field	Value	IRS element (for citing)
Total501c3 Org	14	Total501c3OrgCnt
Total Other Org	0	TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE I, PART I, LINE 1	FormAndLineReferenceDesc
Explanation	ASCO provides assistance to 501(c)(3) organizations that serve the cancer community.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Written Employment Contract	Yes (X)	WrittenEmploymentContractInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	false	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	false	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	false	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	false	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	false	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	false	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	false	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	Yes (true)	AnyNonFixedPaymentsInd
Initial Contract Exception	false	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (18 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Clifford AHudisMDFACPFASCO
CEO, Ex-officio Director	$771,634	$0	$36,058	$0	$0	$0	$20,250	$0	$3,869	$0	$831,811	$0	$0	$0
Richard Schilsky MD
SVP, Chief Medical Officer	$509,346	$0	$30,000	$0	$0	$0	$20,250	$0	$13,957	$0	$573,553	$0	$0	$0
Dina Michels Esq
Senior VP, CLO, SECRETARY	$539,327	$0	$10,000	$0	$0	$0	$20,250	$0	$18,269	$0	$587,846	$0	$0	$0
Linda Jensen CPA
VP, Chief Financial Officer	$359,615	$0	$35,000	$0	$0	$0	$20,250	$0	$13,957	$0	$428,822	$0	$0	$0
Nancy Daly MS MPH
Executive VP, CPO, CC	$356,097	$0	$6,000	$0	$0	$0	$20,250	$0	$13,549	$0	$395,896	$0	$0	$0
Kevin Fitzpatrick
CEO, CancerLinQ	$404,423	$0	$60,000	$0	$0	$0	$20,250	$0	$18,269	$0	$502,942	$0	$0	$0
Jamie Von Roenn MD
VP, Education	$359,615	$0	$10,000	$0	$28,802	$0	$20,250	$0	$13,957	$0	$432,624	$0	$0	$0
Bernie Khoo
VP, Integrated Media	$399,538	$0	$10,000	$0	$0	$0	$20,250	$0	$19,652	$0	$449,440	$0	$0	$0
Stephen Grubbs MD
VP, Clinical Affairs	$359,623	$0	$20,000	$0	$0	$0	$20,250	$0	$11,125	$0	$410,998	$0	$0	$0
Robert Miller MD
VP, Quality	$341,210	$0	$20,000	$0	$0	$0	$20,250	$0	$18,269	$0	$399,729	$0	$0	$0
Deborah Kamin RN PHD
VP, POLICY AND ADVOCACY	$274,525	$0	$10,000	$0	$0	$0	$20,250	$0	$13,957	$0	$318,732	$0	$0	$0
Kristin Ludwig
VP, Communications	$259,567	$0	$10,000	$0	$0	$0	$19,468	$0	$1,528	$0	$290,563	$0	$0	$0
DAVID DORNSTREICH
DIVISION DIR., MARKET STRAT.	$250,250	$0	$5,500	$0	$0	$0	$18,769	$0	$13,957	$0	$288,476	$0	$0	$0
JENNIFER WONG
CHIEF, STRATEGIC ALLIANCES	$252,067	$0	$2,450	$0	$0	$0	$18,905	$0	$11,125	$0	$284,547	$0	$0	$0
David Sampson
VP, Publications	$224,615	$0	$10,000	$0	$0	$0	$16,846	$0	$18,269	$0	$269,730	$0	$0	$0
Krista Barnes
VP, Member Services	$209,615	$0	$10,000	$0	$0	$0	$15,721	$0	$18,269	$0	$253,605	$0	$0	$0
Mandy Davis-Aitken
VP, Meeting Services	$158,734	$0	$3,877	$0	$0	$0	$11,905	$0	$7,387	$0	$181,903	$0	$0	$0
JEAN COLVARD
VP MEETING SERVICES	$139,577		$10,000	$0	$0	$0	$10,468	$0	$4,264	$0	$164,309	$0	$0	$0

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Part I, Line 7:	FormAndLineReferenceDesc
Explanation	PERFORMANCE-BASED BONUS PAYMENTS CAN BE MADE TO SOME EMPLOYEES LISTED ON SCHEDULE J AND INCLUDED AS PART OF THE TOTAL COMPENSATION. THE BONUS PAYMENTS ARE NOT ON A FIXED BASIS BUT RATHER ARE BASED ON PERFORMANCE AND DETERMINED BY THE CEO WITH REVIEW AND APPROVAL BY THE COMPENSATION COMMITTEE OF THE BOARD, WHERE APPROPRIATE.	ExplanationTxt

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd

Issuer Name IssuerName

Field	Value	IRS element (for citing)
Business Name Line1	INDUSTRIAL DEVELOPMENT AUTHORITYCITY OF ALEXANDRI	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Bond Issuer EIN	521381432	BondIssuerEIN
CUSIP	01530LAD2	CUSIPNum
Bond Issued	2012-08-01	BondIssuedDt
Issue Price	$38,400,000	IssuePriceAmt
Purpose	Buy/Buildout 5 floors HQ building	PurposeDesc
Defeased	false	DefeasedInd
On Behalf Of Issuer	false	OnBehalfOfIssuerInd
Pool Financing	false	PoolFinancingInd

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Retired	$0	RetiredAmt
Bond Defeased	$0	BondDefeasedAmt
Total Proceeds	$38,400,000	TotalProceedsAmt
In Reserve Fund	$0	InReserveFundAmt
Capitalized Interest	$0	CapitalizedInterestAmt
Refunding Escrow	$0	RefundingEscrowAmt
Issuance Costs From Proceeds	$0	IssuanceCostsFromProceedsAmt
Credit Enhancement	$0	CreditEnhancementAmt
Working Capital Expenditures	$0	WorkingCapitalExpendituresAmt
Capital Expenditures	$38,400,000	CapitalExpendituresAmt
Other Spent Proceeds	$0	OtherSpentProceedsAmt
Unspent	$0	UnspentAmt
Substantial Completion	2008	SubstantialCompletionYr
Current Refunding	false	CurrentRefundingInd
Advance Refunding	false	AdvanceRefundingInd
Final Allocation Made	Yes (true)	FinalAllocationMadeInd
Adequate Books And Rec Maint	Yes (true)	AdequateBooksAndRecMaintInd

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Owning Bond Financed Property	false	OwningBondFinancedPropertyInd
Any Lease Arrangements	false	AnyLeaseArrangementsInd
Mgmt Contract Bond Fincd Prop	Yes (true)	MgmtContractBondFincdPropInd
Engage Bond Counsel Contracts	Yes (true)	EngageBondCounselContractsInd
Any Research Agreements	false	AnyResearchAgreementsInd
Private Bus Use By Others	0.00000	PrivateBusUseByOthersPct
Private Bus Concerning UBI	0.00500	PrivateBusConcerningUBIPct
Total Private Business Use	0.00500	TotalPrivateBusinessUsePct
Bond Iss Meet Prvt Sec Pymt Test	false	BondIssMeetPrvtSecPymtTestInd
Change In Use Bond Financed Prop	false	ChangeInUseBondFinancedPropInd
Remedial Action Taken	false	RemedialActionTakenInd
Procs Nonqualified Bond Remdtd	Yes (true)	ProcsNonqualifiedBondRemdtdInd

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Form8038 T Filed	false	Form8038TFiledInd
Rebate Not Due Yet	false	RebateNotDueYetInd
Exception To Rebate	false	ExceptionToRebateInd
No Rebate Due	Yes (true)	NoRebateDueInd
Variable Rate Issue	Yes (true)	VariableRateIssueInd
Hedge Identified In Bks And Rec	Yes (true)	HedgeIdentifiedInBksAndRecInd

Hedge Provider Name HedgeProviderName

Field	Value	IRS element (for citing)
Business Name Line1	FMS Wentworth	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Term Of Hedge	30.	TermOfHedgePct
Superintegrated Hedge	false	SuperintegratedHedgeInd
Hedge Terminated	false	HedgeTerminatedInd
Gross Proceeds Invested In GIC	false	GrossProceedsInvestedInGICInd

GIC Provider Name GICProviderName

Field	Value	IRS element (for citing)
Business Name Line1	0	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Gross Proceeds Invested	false	GrossProceedsInvestedInd
Written Proc To Monitor Reqs	Yes (true)	WrittenProcToMonitorReqsInd

Procedures Corrective Action ProceduresCorrectiveActionGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Procedures Corrective Action	Yes (true)	ProceduresCorrectiveActionInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc

ExplanationExplanationTxt

PART IV, QUESTION 3

ASCO has an interest rate swap agreement with FMS Wentworth Bank through 2038. ASCO makes fixed interest payments at a 3.587% rate. Variable swap payments, based on one-month LIBOR, received from the swap counterparty are used to make the variable interest payments as they come due. These interest rate swap agreements qualify as a derivative instrument and are used to mitigate the effect of interest rate fluctuations.

part iv, question 2c

The latest rebate computation date for the reported bond issue was September 27, 2017.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (17 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART III, LINE 1	ASCO IS A PROFESSIONAL ONCOLOGY SOCIETY COMMITTED TO CONQUERING CANCER THROUGH RESEARCH, EDUCATION, AND PROMOTION OF THE HIGHEST QUALITY PATIENT CARE. ASCO'S VISION IS A WORLD WHERE CANCER IS PREVENTED OR CURED, AND EVERY SURVIVOR IS HEALTHY. ASCO PROMOTES AND PROVIDES FOR: - LIFELONG LEARNING FOR ONCOLOGY PROFESSIONALS, - CANCER RESEARCH, - AN IMPROVED ENVIRONMENT FOR ONCOLOGY PRACTICE, - ACCESS TO QUALITY CANCE CARE, - A GLOBAL NETWORK OF ONCOLOGY EXPERTISE, AND - EDUCATED AND INFORMED PATIENTS WITH CANCER.
FORM 990, PART III, LINE 4A	EDUCATIONAL AND SCIENTIFIC MEETINGS AND PRODUCTS: ASCO PROVIDES EDUCATIONAL AND SCIENTIFIC PROGRAMS AND CONTENT ON A VARIETY OF ONCOLOGY-RELATED TOPICS IN A VARIETY OF FORMATS. WORKING WITH VOLUNTEER ASCO MEMBERS, ASCO PLANS AND PRESENTS LIVE MEETINGS ON CUTTING EDGE RESEARCH AND SCIENCE IN THE FIELD OF CLINICAL ONCOLOGY. THE SCIENTIFIC RESEARCH AND EDUCATION PRESENTED AT THE MEETINGS ENHANCES KNOWLEDGE ABOUT CANCER, THUS ADVANCING HIGH-QUALITY CANCER CARE. THE ASCO ANNUAL MEETING IS THE WORLD'S PREMIER EDUCATIONAL AND SCIENTIFIC MEETING IN THE ONCOLOGY COMMUNITY AND THE THEMATIC MEETINGS PRESENTED OR CO-SPONSORED BY ASCO PROVIDE OPPORTUNITIES FOR FOCUSED EDUCATIONAL AND SCIENTIFIC PROGRAMMING ON SPECIFIC TYPES OF CANCERS. ASCO'S EDUCATIONAL AND SCIENTIFIC PROGRAMS SERVE THE DIVERSE NEEDS OF ONCOLOGY PRACTITIONERS WORLDWIDE AND ASSIST THEM IN PROVIDING WORLD CLASS CANCER CARE AND IN CONDUCTING CUTTING EDGE RESEARCH THROUGH THE CONTINUUM OF THEIR CAREERS. APPROPRIATE PROGRAMS ARE PROVIDED FOR ONCOLOGY FELLOWS, JUNIOR FACULTY MEMBERS, ONCOLOGY PROGRAM DIRECTORS, AND OTHERS TO MEET THE CHANGING NEEDS OF PEOPLE LIVING WITH CANCER AND ADDRESS THE MODERN-DAY PRACTICE OF ONCOLOGY. WORKING WITH VOLUNTEER ASCO MEMBERS, ASCO PLANS, IMPLEMENTS AND EVALUATES CONTINUING MEDICAL EDUCATION (CME) TO SUPPORT THE CONTINUED EDUCATION OF ONCOLOGISTS SO THAT THEY ARE BETTER PREPARED TO MEET THE PREVENTION, DIAGNOSIS AND TREATMENT NEEDS OF THEIR PATIENTS. CURRENTLY,ASCO HOLDS THE STATUS OF ACCREDITATION WITH COMMENDATION FROM THE ACCREDITATION COUNCIL FOR CME FOR ASCO'S CME PROGRAM. ASCO MAKES MUCH OF THE CONTENT FROM ITS MEETINGS AND OTHER EDUCATIONAL AND SCIENTIFIC CONTENT AVAILABLE TO THE GENERAL PUBLIC THROUGH TWO ASCO WEBSITES: WWW.ASCO.ORG AND WWW.CANCER.NET. ADDITIONALLY, ASCO MAKES EDUCATIONAL AND SCIENTIFIC MATERIALS AVAILABLE THROUGH A VARIETY OF CHANNELS, INCLUDING BOOKS, DVDS, VIRTUAL MEETINGS, PODCASTS AND PUBLIC FORUMS. HIGHLIGHTS OF THE 2017 ACTIVITIES INCLUDE: OVER 39,000 PEOPLE ATTENDED THE 2017 ASCO ANNUAL MEETING, INCLUDING PHYSICIANS, NURSES,CAREGIVERS, PATIENTS, AND PATIENT ADVOCATES. APPROXIMATELY 40% OF THE ATTENDEES AT THE 2017 ASCO ANNUAL MEETING WERE INTERNATIONAL ATTENDEES. THE 2017 ANNUAL MEETING FEATURED OVER 265 EDUCATIONAL AND SCIENTIFIC SESSIONS AND OVER 5,000 ABSTRACTS WERE PRESENTED OR PUBLISHED. NEARLY 3,000 PRESENTATIONS WERE CAPTURED IN AUDIO AND VIDEO TO BE MADE AVAILABLE ELECTRONICALLY. IN ADDITION TO THE ASCO ANNUAL MEETING, ASCO SPONSORED OR CO-SPONSORED OVER 50 EDUCATIONAL AND SCIENTIFIC SYMPOSIA, WORKSHOPS, AND COURSES INSIDE AND OUTSIDE THE UNITED STATES ON A WIDE VARIETY OF CANCER-RELATED TOPICS TO IMPROVE ONCOLOGY CARE IN AND AROUND THE WORLD. THESE MEETINGS INCLUDED: - BEST OF ASCO - Palliative and Supportive Care in Oncology Symposium - QUALITY CARE SYMPOSIUM - GI CANCERS SYMPOSIUM - GU CANCERS SYMPOSIUM - CANCER SURVIVORSHIP SYMPOSIUM INTERNATIONAL AFFAIRS MEETINGS AND COURSES: - BEST OF ASCO INTERNATIONAL - JOINT SYMPOSIA - ADVANCED CANCER COURSES - MULTIDISCIPLINARY CANCER MANAGEMENT COURSES ASCO PUBLISHES DAILY NEWS PRODUCTS FOR EACH OF ITS MAJOR LIVE MEETINGS. THE DAILY NEWS PRODUCTS INCLUDE PRINT NEWSPAPERS THAT ARE DISTRIBUTED ONSITE TO ALL ATTENDEES AT THE LIVE EVENT AND ONLINE (THE ENTIRETY OF THE PRINT VERSIONS PLUS BONUS COVERAGE) TO ASCO MEMBERS AND TO THE GENERAL PUBLIC. THE DAILY NEWS PRODUCTS INCLUDE COVERAGE OF KEY EDUCATIONAL AND SCIENTIFIC SESSIONS, EDITORIALS BY EXPERTS IN VARIOUS SUBSPECIALTIES, INFORMATION ABOUT ASCO PRODUCTS AND RESOURCES, PROFILES OF GRANT AND AWARD WINNERS, AND COMMENTARY AND TOPICS OF INTEREST TO INTERNATIONAL ATTENDEES AND MEMBERS.
FORM 990, PART III, LINE 4B	QUALITY: ASCO develops evidence-based guidelines, develops and validates quality measures in oncology, and conducts quality improvement and measurement activities. PROGRAMS INCLUDE: - CANCERLINQ, AN INITIATIVE TO DEVELOP A RAPID LEARNING SYSTEM IN ONCOLOGY. THIS EFFORT IS INTENDED TO TRANSFORM THE WAY ONCOLOGISTS PRACTICE, LEARN, AND INTERACT WITH THEIR PATIENTS. - QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI). A QUALITY ASSESSMENT AND IMPROVEMENT PROGRAM FOR OUTPATIENT MEDICAL ONCOLOGY AND HEMATOLOGY-ONCOLOGY PRACTICES. QOPI PROVIDES A WEB-BASED DATA COLLECTION TOOL THAT ALLOWS PRACTICE STAFF TO 1) REPORT ON VARIOUS CANCER CARE QUALITY MEASURES, 2) RECEIVE ANALYZED DATA ON PRACTICE PERFORMANCE, AND 3) COMPARE PERFORMANCE AGAINST THEIR PEERS FOR DATA-DRIVEN IMPROVEMENT ACTIVITIES. - QOPI CERTIFICATION PROGRAM. THE QOPI CERTIFICATION PROGRAM BUILDS UPON THE SUCCESS OF QOPI. QOPI CERTIFICATION DEMONSTRATES A COMMITMENT TO EXCELLENCE AND ONGOING QUALITY IMPROVEMENT IN THE HEMATOLOGY-ONCOLOGY OUTPATIENT PRACTICE. THE GOALS OF THE QOPI CERTIFICATION PROGRAM ARE TO: - PROMOTE HIGH QUALITY CANCER CARE AS DEFINED BY THE CLINICIAN EXPERTS. - PROVIDE A TRUSTED SOLUTION TO SATISFY EXTERNAL DEMAND FOR QUALITY ACTIVITIES. - REDUCE REDUNDANT PROGRAMS OR ADMINISTRATIVE BURDENS RELATED TO THE DEMONSTRATION OF QUALITY. - NEW GUIDELINES AND ONGOING UPDATES. ASCO HAS PUBLISHED OVER 50 PRACTICE GUIDELINES, ENDORSEMENTS, AND PROVISIONAL CLINICAL OPINIONS (PCO'S) ADDRESSING A WIDE RANGE OF CANCER TREATMENT, DIAGNOSIS, AND MANAGEMENT ISSUES.
FORM 990, PART III, LINE 4C	EDUCATIONAL PUBLICATIONS: ASCO PUBLISHES SEVERAL EDUCATIONAL JOURNALS ADDRESSING CLINICAL ONCOLOGY THAT ARE AVAILABLE TO THE PUBLIC. JOURNAL OF CLINICAL ONCOLOGY (JCO) IS A HIGHLY REGARDED, PEER-REVIEWED JOURNAL THAT DISSEMINATES QUALITY ARTICLES ON SIGNIFICANT CLINICAL ONCOLOGY RESEARCH IN PRINT AND ELECTRONIC FORMATS. JOURNAL OF ONCOLOGY PRACTICE (JOP) INCLUDES ORIGINAL RESEARCH AND PERSPECTIVES ON CLINICAL AND ADMINISTRATIVE MANAGEMENT ADDRESSING THE PRACTICE OF ONCOLOGY, WHICH ARE EDITED BY ONCOLOGISTS. THE JOURNAL OF GLOBAL ONCOLOGY (JGO) IS AN ONLINE ONLY, OPEN ACCESS JOURNAL FOCUSED ON CANCER CARE, RESEARCH AND CARE DELIVERY ISSUES UNIQUE TO COUNTRIES AND SETTINGS WITH LIMITED HEALTHCARE RESOURCES. JCO CLINICAL CANCER INFORMATICS IS AN ONLINE-ONLY INTERDISCIPLINARY JOURNAL PUBLISHING CLINICALLY RELEVANT RESEARCH BASED ON BIOMEDICAL INFORMATICS METHODS AND PROCESSES APPLIED TO CANCER-RELATED DATA, INFORMATION AND IMAGES. JCO PRECISION ONCOLOGY IS A PEER-REVIEWED, ONLINE-ONLY, ARTICLE BASED JOURNAL PUBLISHING ORIGINAL RESEARCH, REPORTS, OPINIONS AND REVIEWS THAT ADVANCE THE SCIENCE AND PRACTICE OF PRECISION ONCOLOGY AND DEFINE GENOMICS-DRIVEN CLINICAL CARE OF PATIENTS WITH CANCER.
FORM 990, PART III, LINE 4D	CANCER POLICY AND CLINICAL AFFAIRS: ASCO addresses policy issues raised in the practice of oncology, cancer research, care, and prevention by working with volunteer committees and ASCO leaders to shape policy, law and regulation of issues of importance in oncology. ASCOs policy and clinical affairs programs cover a broad spectrum of issues, including patient-oriented research, health insurance, clinical practice, workforce, disparities, cost/access, cancer survivorship, and cancer prevention and control. ACTIVITIES INCLUDE HOTLINES, TOOLS, EDUCATIONAL WORKSHOPS AND MATERIALS, LEGAL ANALYSIS, DEVELOPMENT OF FORMAL COMMENTS AND TESTIMONY, ADVOCACY, AND SPECIAL STUDIES ON CRITICAL ISSUES FOR THE CANCER COMMUNITY. ASCO staff interact and collaborate on a regular basis with ASCO state and regional affiliates, OTHER MEDICAL SPECIALTY AND PROFESSIONAL SOCIETIES, CONGRESS, THE ADMINISTRATION, AND PATIENT ADVOCATE ORGANIZATIONS TO ADVANCE COMMON GOALS RELATED TO CANCER RESEARCH AND QUALITY CARE. THE STATE/REGIONAL AFFILIATE PROGRAM - THE AFFILIATE PROGRAM WAS CREATED IN 1993 TO BETTER ADDRESS ISSUES RAISED IN THE PRACTICE OF ONCOLOGY, AND TO FACILITATE ASCO'S OWN ADVOCACY PROGRAMS. THE 48 STATE/REGIONAL AFFILIATES INTERACT WITH ASCO THROUGH THE STATE AFFILIATE COUNCIL, WHERE EACH SOCIETY HAS A VOTING REPRESENTATIVE CHARGED WITH SERVING AS THE BRIDGE BETWEEN THE SOCIETY AND ASCO. AFFILIATES HAVE ACCESS TO A NUMBER OF PROGRAMS INCLUDING STATE SOCIETY MEMBERSHIP RECRUITMENT AND RETENTION ASSISTANCE, LEADERSHIP TRAINING, FEDERAL-LEVEL ADVOCACY SUPPORT, EDUCATION AND RESOURCES ON PRACTICE-RELATED ISSUES, AND A WEBSITE DEVELOPMENT TOOL. ORIGINAL DATA COLLECTION - ASCO CONDUCTS STUDIES AND ANALYSES TO ASSESS THE CURRENT STATE OF ONCOLOGY CARE AND RESEARCH AND DETERMINE THE NEED FOR AND IMPACT OF POLICY CHANGES. EXPENSES $18,436,967. INCLUDING GRANTS OF $0. REVENUE $363,711. MEMBER RELATIONS AND INFORMATION: ASCO WORKS TO SUPPORT AND EDUCATE ITS MORE THAN 44,000 MEMBERS THROUGH ITS DAILY ACTIVITIES, INCLUDING PROCESSING NEW MEMBERSHIP APPLICATIONS AND MEMBER DUES, PHONE AND EMAIL COMMUNICATIONS, RESEARCHING AND FULFILLING MEMBER REQUESTS, MAINTAINING THE INTEGRITY OF MEMBER DATA, AND NEW MEMBER RECRUITMENT AND RETENTION EFFORTS. ASCO CONNECTION IS THE OFFICIAL BIMONTHLY MEMBER MAGAZINE FOR AND ABOUT MEMBERS OF ASCO. IT IS THE PRIMARY SOURCE OF INFORMATION ABOUT ASCO'S PROGRAMS AND SERVICES. ALONG WITH ITS COMPANION PROFESSIONAL NETWORKING SITE, ASCOCONNECTION.ORG, ASCO CONNECTION PROMOTES OPPORTUNITIES FOR INTERACTION BETWEEN ASCO AND ITS MEMBERS, AND MEMBERS AND THEIR COLLEAGUES TO FACILITATE THE DISSEMINATION OF INFORMATION RELATING TO CUTTING EDGE RESEARCH, BEST PRACTICES STANDARDS, AND TREATMENT OF PATIENTS. ASCOCONNECTION.ORG FEATURES COMMENTARY BY LEADERS IN THE FIELD, DISCUSSION FORUMS, ONLINE EXCLUSIVES AND COMMENT-ENABLED ARTICLES FROM THE MEMBER MAGAZINE, AND OPPORTUNITIES TO CREATE GROUPS. EXPENSES $4,754,433. INCLUDING GRANTS OF $0. REVENUE $7,936,273. COMMUNICATIONS AND PATIENT INFORMATION: ASCO PROVIDES THE PUBLIC, INCLUDING PATIENTS, THE MEDIA, LEGISLATORS, PHYSICIANS AND OTHER HEALTH CARE PROFESSIONALS, WITH ACCURATE INFORMATION ABOUT CANCER, CANCER CARE, TREATMENT, RESEARCH, PREVENTION, AND OTHER ISSUES IMPORTANT TO THE CANCER COMMUNITY. ASCO HAS A FREE PATIENT EDUCATION WEBSITE, CANCER.NET (WWW.CANCER.NET), AVAILABLE TO THE PUBLIC, INCLUDING PATIENTS, THEIR CAREGIVERS, FAMILY MEMBERS AND FRIENDS, THE MEDIA AND HEALTH CARE PROFESSIONALS, THAT PROVIDES UP-TO-DATE INFORMATION ABOUT CANCER, CANCER CARE, TREATMENT, SURVIVORSHIP, RESEARCH, PREVENTION, AND OTHER ISSUES IMPORTANT TO THE CANCER COMMUNITY. THE SITE OFFERS MEDICAL INFORMATION ON MORE THAN 120 TYPES OF CANCER AND RELATED SYNDROMES, CLINICAL TRIALS, MANAGING SIDE EFFECTS, CAREGIVING, AND HOW TO COPE WITH THE EMOTIONAL AND SOCIAL EFFECTS OF LIVING WITH CANCER. IN ADDITION TO ITS WEBSITE CONTENT, ASCO OFFERS PRINTED MATERIALS FOR PATIENTS, SUCH AS: CANCER.NET'S GUIDES TO CANCER (DETAILED GUIDES COVERING SYMPTOMS, RISK FACTORS, DIAGNOSIS, STAGING, TREATMENT,CLINICAL TRIAL RESOURCES, SIDE EFFECTS, AFTER TREATMENT, CURRENT RESEARCH AND QUESTIONS TO ASK THE DOCTOR), ASCO ANSWERS FACT SHEETS (A SERIES OF FACT SHEETS THAT PROVIDE AN INTRODUCTION TO A SPECIFIC TYPE OF CANCER OR CANCER-RELATED TOPIC, INCLUDING AN OVERVIEW, AN ILLUSTRATION OF WHERE IT STARTS, HOW IT IS TREATED, TERMS TO KNOW, QUESTIONS TO ASK THE DOCTOR), BOOKLETS ON TOBACCO CESSATION, CANCER SURVIVORSHIP, ADVANCED CANCER CARE PLANNING, MANAGING THE COST OF CANCER CARE, AND CANCER IN OLDER ADULTS. ADDITIONAL RESOURCES AVAILABLE ON CANCER.NET. EXPENSES $9,767,302. INCLUDING GRANTS OF $0. REVENUE $166,635.
FORM 990, PART VI, SECTION A, LINE 1	As of december 31, 2017, the board of directors of asco included 18 members with the right to vote on all matters that come before the board of directors. The board of directors also includes two ex-officio directors without the right to vote, who are the chief executive officer of asco (ceo) and the chair of the board of directors of conquer cancer foundation of the american society of clinical oncology (a non-profit, 501(c)(3) tax-exempt related organization of asco). During the reporting year, the board of directors delegated authority to act on its behalf to the executive committee of the board of directors, consistent with asco's bylaws. The voting members of the executive committee were: the president, president-elect, the chair, the past president, and those directors serving the final year of their present terms. The ceo is a non-voting member of the executive committee. All executive committee members are members of asco's board of directors. The scope of the executive committee's authority is established by asco's bylaws, which provide that, except to the extent specifically prohibited by resolution of the board of directors or otherwise prohibited by law, the executive committee of the board is empowered to make and implement major decisions between board meetings and it may act on items requiring action prior to the next announced board of directors. All actions of the executive committee are reported to the board of directors at the next meeting of the board of directors immediately following the action taken by the executive committee, consistent with asco's bylaws.
FORM 990, PART VI, SECTION A, LINE 6	ASCO MEMBERS ARE ELECTED BY THE BOARD OF DIRECTORS, CONSISTENT WITH ASCO'S BYLAWS. NO MEMBER IS ENTITLED TO RECEIVE A SHARE OF ASCOS PROFITS OR EXCESS DUES OR A SHARE OF ASCOS NET ASSETS UPON DISSOLUTION. THE CATEGORIES OF MEMBERSHIP WITH VOTING RIGHTS AND SPECIFIED RIGHTS ARE AS FOLLOWS:1. FULL MEMBERS. 1.A. FULL MEMBERS ARE (A) EXPERIENCED LICENSED PHYSICIANS OF ANY NATION WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO CANCER PATIENT CARE AND/OR RESEARCH OR EDUCATION IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER (IN EXCEPTIONAL CASES, OTHER PHYSICIANS WHO HAVE MADE SIGNIFICANT CONTRIBUTIONS TO THE FIELD ARE ELIGIBLE FOR FULL MEMBER STATUS), AND (B) OTHER HEALTH PROFESSIONALS AT THE DOCTORAL LEVEL (E.G.,EPIDEMIOLOGISTS, BIOSTATISTICIANS, PUBLIC HEALTH SPECIALISTS, NURSES, OTHER SCIENTISTS, ETC.) OR INDIVIDUALS WITH EQUIVALENT ACADEMIC RANKS WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO CANCER PATIENT CARE AND/OR RESEARCH OR EDUCATION IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER. 1.B. RIGHTS OF FULL MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS, VOTE ON THE ELECTION OF ELECTED DIRECTORS, ELECTED OFFICERS, AND CERTAIN COMMITTEE MEMBERS, AND APPROVE SIGNIFICANT DECISIONS OF THE GOVERNING BODY SUCH AS AMENDMENT TO THE GOVERNING DOCUMENTS AND DISSOLUTION. 2. EMERITUS MEMBERS. 2.A. EMERITUS MEMBERS ARE FULL, ALLIED PHYSICIAN/DOCTORAL SCIENTIST, INTERNATIONAL CORRESPONDING AND AFFILIATED HEALTH PROFESSIONAL MEMBERS WHO HAVE REQUESTED EMERITUS STATUS AT AGE 70, UPON RETIREMENT OR EARLIER IF PERMANENTLY DISABLED. 2.B. EMERITUS MEMBERS WHO AT THE TIME OF THE REQUEST WERE FULL MEMBERS RETAIN THE RIGHT TO ATTEND MEETINGS, VOTE ON THE ELECTION OF ELECTED DIRECTORS, ELECTED OFFICERS, AND CERTAIN COMMITTEE MEMBERS, AND APPROVE SIGNIFICANT DECISIONS OF THE GOVERNING BODY SUCH AS AMENDMENT TO THE GOVERNING DOCUMENTS AND DISSOLUTION.3. HONORARY MEMBERS. 3.A. HONORARY MEMBERS ARE INDIVIDUALS WHO HAVE MADE AN OUTSTANDING CONTRIBUTION TO CLINICAL ONCOLOGY WHO ARE DESIGNATED AS AN HONORARY MEMBER BY THE BOARD OF DIRECTORS. 3.B. MEMBERS HAVE THE RIGHT TO ATTEND MEETINGS, VOTE ON THE ELECTION OF ELECTED DIRECTORS, ELECTED OFFICERS, AND CERTAIN COMMITTEE MEMBERS, AND APPROVE SIGNIFICANT DECISIONS OF THE GOVERNING BODY SUCH AS AMENDMENT TO THE GOVERNING DOCUMENTS AND DISSOLUTION.
FORM 990, PART VI, SECTION A, LINE 7A	VOTING MEMBERS OF ASCO ELECT ALL 18 VOTING MEMBERS OF THE ASCO BOARD OF DIRECTORS. THE CATEGORIES OF MEMBERS WHO ARE ELIGIBLE TO VOTE FOR THE ELECTION OF MEMBERS OF THE GOVERNING BODY ARE: FULL MEMBERS, EMERITUS MEMBERS WHO WERE FULL MEMBERS AT THE TIME OF REQUEST FOR EMERITUS MEMBER STATUS, AND HONORARY MEMBERS.
FORM 990, PART VI, SECTION A, LINE 7B	ASCOS CERTIFICATE OF INCORPORATION MAY ONLY BE AMENDED UPON THE VOTE OF THE MEMBERS ENTITLED TO VOTE, AND THE BYLAWS MAY ONLY BE AMENDED AND DISSOLUTION OF THE CORPORATION MAY ONLY BE APPROVED WITH THE APPROVAL OF BOTH THE BOARD OF DIRECTORS AND VOTING MEMBERS OF ASCO. THE CATEGORIES OF MEMBERS WHO ARE ELIGIBLE TO VOTE ARE: FULL MEMBERS, EMERITUS MEMBERS WHO WERE FULL MEMBERS AT THE TIME OF REQUEST FOR EMERITUS MEMBER STATUS, AND HONORARY MEMBERS.
FORM 990, PART VI, SECTION B, LINE 11	AN ELECTRONIC COPY OF THE ASCO FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS AND WAS DISCUSSED AT A MEETING OF THE BOARD BEFORE IT WAS FILED. THE ASCO FORM 990 WAS REVIEWED BY THE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER, THE CHIEF EXECUTIVE OFFICER, AND THE SENIOR VICE PRESIDENT AND CHIEF LEGAL OFFICER PRIOR TO FILING.
FORM 990, PART VI, SECTION B, LINE 12C	ASCO MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL ASCO MEMBERS AND EMPLOYEES, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS INVOLVING THE SHARING OF INCOME OR ASSETS (E.G. SPOUSE, DEPENDENT CHILDREN). COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS, CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE ALSO REQUIRED TO DISCLOSE SERVICE AS AN OFFICER, DIRECTOR, OR TRUSTEE OF ANY OTHER PROFESSIONAL OR ADVOCACY ORGANIZATION RELATING TO SCIENCE OR HEALTH CARE. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE AND UPDATED ANNUALLY THEREAFTER OR WHEN ANY MATERIAL CHANGES OCCUR. ASCO'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, IF ASCO WERE TO CONTEMPLATE ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY INTERESTED PERSON (I.E. AN ASCO DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF AN ASCO COMMITTEE WITH BOARD DELEGATED POWERS WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST.
FORM 990, PART VI, SECTION B, LINE 15	Compensation of chief executive officer (ceo): the duties of the ceo of asco include serving as: the ceo of asco, the ceo of asco's non-profit, 501(c)(3) tax-exempt related organization, conquer cancer foundation of clinical oncology (cc); qopi certification program, llc; the president of asco leasing llc, and the chair of the board of directors of cancerlinq llc. All organizations listed are related organizations of asco. The written employment contract between the ceo and asco addresses compensation of the ceo. The compensation of the ceo was determined by the asco board of directors, following the review and recommendation of the board compensation committee. The compensation committee consulted with independent legal counsel and its independent compensation consultant. The independent compensation consultant collected and reported on comparable market data (including data on comparable compensation for similarly qualified persons in functionally comparable positions at similarly situated organizations) and provided its opinion that the compensation for the ceo was reasonable. The review, recommendation, and determination of the ceo's compensation based on the above described process were most recently undertaken in 2017. Vice President AND Chief Financial Officer: the compensation of the Vice President AND Chief Financial Officer (VP & CFO) was considered and approved by the board compensation committee, after receiving the recommendation of the ceo and consulting with independent legal counsel and its independent compensation consultant as follows. The independent compensation consultant collected and reported on comparable market data (including data on comparable compensation for similarly qualified persons in functionally comparable positions at similarly situated organizations) and provided its opinion that the proposed compensation for the VP & cfo was reasonable. The consideration and approval of the compensation of the VP & cfo based on the above described process were most recently undertaken in 2017. Senior Vice President & Chief Medical Officer: the compensation of the Senior Vice President & Chief Medical Officer (SVP & CMO) was considered and approved by the Board Compensation Committee, after receiving the recommendation of the CEO and consulting with independent legal counsel and its independent compensation consultant as follows. The independent compensation consultant collected and reported on comparable market data (including data on comparable compensation for similarly qualified persons in functionally comparable positions at similarly situated organizations) and provided its opinion that the compensation for the SVP & CMO was reasonable. The written employment contract between the SVP & CMO and ASCO address compensation of the SVP & CMO. The consideration and approval of the compensation of the SVP & CMO based on the above described process was most recently undertaken in 2017. Executive Vice President & Chief Philanthropic Officer of the conquer cancer foundation of clinical oncology (cc): the Executive Vice President & Chief Philanthropic Officer of CC is an employee of asco. The asco board compensation committee considered and approved the compensation of the Executive Vice President & Chief Philanthropic Officer of CC after receiving the recommendation of the ceo and consulting with independent legal counsel and its independent compensation consultant as follows. The independent compensation consultant collected and reported on comparable market data (including data on comparable compensation for similarly qualified persons in functionally comparable positions at similarly situated organizations) and provided its opinion that the compensation of the Executive Vice President & Chief Philanthropic Officer of CC was reasonable. The consideration and approval of the compensation of the Executive Vice President & Chief Philanthropic Officer of CC based on the above described process were most recently undertaken in 2017. Chief Executive Officer of CancerLinQ LLC: the compensation of the Chief Executive Officer of CancerLinQ LLC (CEO of CLQ) was considered and approved by the Board Compensation Committee, after receiving the recommendation of the CEO and consulting with independent legal counsel and its independent compensation consultant as follows. The independent compensation consultant collected and reported on comparable market data (including data on comparable compensation for similarly qualified persons in functionally comparable positions at similarly situated organizations) and provided its opinion that the compensation for the CEO of CLQ was reasonable. The consideration and approval of the compensation of the SVP & CMO based on the above described process was most recently undertaken in 2017. Vice president, integrated media and technology: the compensation of the vice president, integrated media and technology was considered and approved by the board compensation committee, after receiving the recommendation of the ceo and consulting with independent legal counsel and its independent compensation consultant as follows. The independent compensation consultant collected and reported on comparable market data (including data on comparable compensation for similarly qualified persons in functionally comparable positions at similarly situated organizations) and provided its opinion that the compensation of the vice president, integrated media and technology was reasonable. The consideration and approval of the compensation of the vice president, integrated media and technology based on the above described process were most recently undertaken in 2017.
FORM 990, PART VI, SECTION C, LINE 19	ASCO'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. ASCO'S CERTIFICATE OF INCORPORATION IS ALSO AVAILABLE TO THE PUBLIC THROUGH THE SECRETARY OF STATE OF NEW YORK. ASCO'S CONFLICT OF INTEREST POLICY IS POSTED ON ASCO'S WEBSITE, AND IS AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. ASCO'S ANNUAL REPORT IS POSTED ON ASCO'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST.
FORM 990, PART XI, LINE 9	GAIN ON INTEREST RATE SWAP $1,289,983
FORM 990 PART IX LINE 11G	DESCRIPTION:COMMISSIONS TOTAL FEES:4976661
FORM 990 PART IX LINE 11G	DESCRIPTION:PUBLIC RELATIONS COORDINATOR TOTAL FEES:1266105
FORM 990 PART IX LINE 11G	DESCRIPTION:OTHER PROFESSIONAL SERVICES TOTAL FEES:11940341

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp (3 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Total IncomeTotalIncomeAmt	End Of Year AssetsEndOfYearAssetsAmt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt
QOPI Certification Program LLC
2318 MILL ROAD	ALEXANDRIA	VA	22314	271629211	accreditation	VA	$2,117,459	-$383,515	ASCO
ASCO LEASING LLC
2318 MILL ROAD	ALEXANDRIA	VA	22314	273378225	RENTAL	VA	$1,163,863	$359,603	ASCO
CANCERLINQ LLC
2318 MILL ROAD	ALEXANDRIA	VA	22314	472315885	QUALITY IMPRO	VA	$11,184,369	$9,564,874	ASCO

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

Field	Value	IRS element (for citing)
Business Name Line1	CONQUER CANCER FOUNDATION OF ASCO	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD	AddressLine1Txt
City	ALEXANDRIA	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22314	ZIPCd

Field	Value	IRS element (for citing)
EIN	311667995	EIN
Primary Activities	Grants	PrimaryActivitiesTxt
Legal Domicile State	VA	LegalDomicileStateCd
Exempt Code Section	501(C)(3)	ExemptCodeSectionTxt
Public Charity Status	7	PublicCharityStatusTxt

Direct Controlling Entity Name DirectControllingEntityName

Field	Value	IRS element (for citing)
Business Name Line1	asco	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Controlled Organization	Yes (true)	ControlledOrganizationInd

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	Yes (true)	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	Yes (true)	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	Yes (true)	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	false	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	Yes (true)	LoansOrGuaranteesFromOthOrgInd
Asset Sale To Other Org	false	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	false	AssetPurchaseFromOtherOrgInd
Asset Exchange	false	AssetExchangeInd
Rental Of Facilities To Oth Org	Yes (true)	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	false	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	false	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	Yes (true)	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	Yes (true)	SharingOfFacilitiesInd
Paid Employees Sharing	Yes (true)	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	Yes (true)	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	Yes (true)	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	false	TransferToOtherOrgInd
Transfer From Other Org	false	TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (8 entries)

Transaction TypeTransactionTypeTxt	InvolvedInvolvedAmt	Method Of Amount DeterminationMethodOfAmountDeterminationTxt
conquer cancer foundation of asco
b	$4,553,000	fmv
conquer cancer foundation of asco
c	$11,641,675	fmv
conquer cancer foundation of asco
e	$58,605,000	fmv
conquer cancer foundation of asco
j	$226,200	fmv
conquer cancer foundation of asco
m	$4,500,000	fmv
conquer cancer foundation of asco
n	$226,200	fmv
conquer cancer foundation of asco
o	$1,478,000	fmv
conquer cancer foundation of asco
q	$114,373	fmv